Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Post by Hiddensecretson Feb 10, 2021 11:55am
200 Views
Post# 32525787

Very STRONG fundmentals...billion $$$ company....

Very STRONG fundmentals...billion $$$ company....It is best to IGNORE the noise that is going on with this stock and to just continue to LOAD UP. 

It is obvious that alot of investors (I should call them traders) sold MEDV and have run off towards pot stocks as they rally. 

The thing is that pot stocks WILL NEVER MAKE the type of $$$ that MEDV is delivering and will continue to deliver. 

FUNDAMENTALS ALWAYS WIN.

Fact is that MEDV had revenue of $ 14 million in January 2021, probably will do double that amount in February and, triple that amount in March 2021.   The eps is simply going to be off the roof.

No pot company will come close to 10% of what MEDV is delivering.

Believe in your due diligence, and BUY BUY BUY.....

Stock at this moment is worth anywhere from $ 6 to $ 12 per share. 

MPO
<< Previous
Bullboard Posts
Next >>